Literature DB >> 11343866

Transmission disequilibrium analysis of HLA class II DRB1, DQA1, DQB1 and DPB1 polymorphisms in schizophrenia using family trios from a Han Chinese population.

T Li1, J Underhill, X H Liu, P C Sham, P Donaldson, R M Murray, P Wright, D A Collier.   

Abstract

Our goal was to evaluate the role of HLA in the risk of developing schizophrenia, in a Han Chinese population. In several Japanese studies, there is evidence of association with DR1 and schizophrenia. A variety of other associations have been reported in other populations, including negative associations with DQbeta(*)0602 and positive associations with DR1(*)0101. Using sequence specific oligonucleotides, we genotyped four HLA markers (DRB1, DQA1, DQB1 and DPB1) in 165 family trios, consisting of Han Chinese schizophrenic subjects and their parents. Individual markers were analysed for transmission distortion in the trios using the transmission disequilibrium test. Multiple haplotype transmission was performed using the program TRANSMIT v2.5. The four markers were in strong linkage disequilibrium with each other (P value from 0.002 to 0). There was no evidence of overall transmission disequilibrium for each of the four loci. For DRB1, we did not find transmission distortion for the DRB1(*)04 and DRB1(*)08 alleles, as reported previously, but the DRB1(*)03 allele was preferentially not transmitted (P=0.009), and the DRB1(*)13 allele was preferentially transmitted from parents to schizophrenic offspring (P=0.041). Using haplotypes of pairs of markers, a significant global P value of 0.019 was achieved when using DRB1 and DQA1, mainly as a result of the excess transmission of DRB1(*)13-DQA1(*)01 (P=0.012) and a deficit in transmission of DRB1(*)03-DQA1(*)05 (P=0.002). In summary, we did not confirm any of the specific HLA allelic associations reported previously in Japanese or other populations. However, our results are compatible with the view that this region of HLA might contain a susceptibility gene which is in linkage disequilibrium with DRB1 and DQA1 genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343866     DOI: 10.1016/s0920-9964(00)00111-0

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

1.  Search for schizophrenia susceptibility variants at the HLA-DRB1 locus among a British population.

Authors:  Lorna Halley; Mary K Doherty; Ian L Megson; Neil McNamara; Andy Gadja; Jun Wei
Journal:  Immunogenetics       Date:  2012-09-29       Impact factor: 2.846

2.  Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44.

Authors:  V Saviouk; E W C Chow; A S Bassett; L M Brzustowicz
Journal:  Mol Psychiatry       Date:  2005-04       Impact factor: 15.992

Review 3.  Immune system disturbances in schizophrenia.

Authors:  Szatmár Horváth; Károly Mirnics
Journal:  Biol Psychiatry       Date:  2013-07-25       Impact factor: 13.382

4.  Association of HLA-DR/DQ polymorphisms with schizophrenia in Tunisian patients.

Authors:  Aicha Sayeh; Cheker Ben Cheikh; Meriem Mrad; Najwa Lakhal; Nasreddine Gritli; Slaheddine Galelli; Abdelaziz Oumaya; Najiba Fekih-Mrissa
Journal:  Ann Saudi Med       Date:  2014 Nov-Dec       Impact factor: 1.526

5.  Integrating genome-wide association study with regulatory SNP annotation information identified candidate genes and pathways for schizophrenia.

Authors:  Xiao Liang; Sen Wang; Li Liu; Yanan Du; Bolun Cheng; Yan Wen; Yan Zhao; Miao Ding; Shiqiang Cheng; Mei Ma; Lu Zhang; Xin Qi; Ping Li; Xiong Guo; Feng Zhang
Journal:  Aging (Albany NY)       Date:  2019-06-07       Impact factor: 5.682

Review 6.  Extra-Intestinal Manifestations of Celiac Disease: What Should We Know in 2022?

Authors:  Marilena Durazzo; Arianna Ferro; Isabella Brascugli; Simone Mattivi; Sharmila Fagoonee; Rinaldo Pellicano
Journal:  J Clin Med       Date:  2022-01-04       Impact factor: 4.241

7.  Common variants conferring risk of schizophrenia.

Authors:  Hreinn Stefansson; Roel A Ophoff; Stacy Steinberg; Ole A Andreassen; Sven Cichon; Dan Rujescu; Thomas Werge; Olli P H Pietiläinen; Ole Mors; Preben B Mortensen; Engilbert Sigurdsson; Omar Gustafsson; Mette Nyegaard; Annamari Tuulio-Henriksson; Andres Ingason; Thomas Hansen; Jaana Suvisaari; Jouko Lonnqvist; Tiina Paunio; Anders D Børglum; Annette Hartmann; Anders Fink-Jensen; Merete Nordentoft; David Hougaard; Bent Norgaard-Pedersen; Yvonne Böttcher; Jes Olesen; René Breuer; Hans-Jürgen Möller; Ina Giegling; Henrik B Rasmussen; Sally Timm; Manuel Mattheisen; István Bitter; János M Réthelyi; Brynja B Magnusdottir; Thordur Sigmundsson; Pall Olason; Gisli Masson; Jeffrey R Gulcher; Magnus Haraldsson; Ragnheidur Fossdal; Thorgeir E Thorgeirsson; Unnur Thorsteinsdottir; Mirella Ruggeri; Sarah Tosato; Barbara Franke; Eric Strengman; Lambertus A Kiemeney; Ingrid Melle; Srdjan Djurovic; Lilia Abramova; Vasily Kaleda; Julio Sanjuan; Rosa de Frutos; Elvira Bramon; Evangelos Vassos; Gillian Fraser; Ulrich Ettinger; Marco Picchioni; Nicholas Walker; Timi Toulopoulou; Anna C Need; Dongliang Ge; Joeng Lim Yoon; Kevin V Shianna; Nelson B Freimer; Rita M Cantor; Robin Murray; Augustine Kong; Vera Golimbet; Angel Carracedo; Celso Arango; Javier Costas; Erik G Jönsson; Lars Terenius; Ingrid Agartz; Hannes Petursson; Markus M Nöthen; Marcella Rietschel; Paul M Matthews; Pierandrea Muglia; Leena Peltonen; David St Clair; David B Goldstein; Kari Stefansson; David A Collier
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

8.  Celiac disease in patients with chronic psychiatric disorders.

Authors:  Manouchehr Khoshbaten; Mohammad Rostami Nejad; Nasrin Sharifi; Ali Fakhari; Mahdyar Golamnejad; Sayed Hassan Hashemi; Pekka Collin; Kamran Rostami
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2012
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.